 |
Homovanillic Acid - Metabolism
Research News and Information
Sunday, November 22, 2009
30 Jul 2009 
BACKGROUND: The selective MAO-B inhibitor selegiline has been evaluated in clinical trials as a potential medication for the treatment of cocaine dependence. This study evaluated the safety of and pharmacologic interactions between 7 days of ... Read more...
6 Jul 2009 Methamphetamine is a commonly abused psychostimulant that causes addiction and is often abused by pregnant women. Acute or chronic administration of methamphetamine elevates the levels of the extracellular monoamine neurotransmitters, such as ... Read more...
Biphasic effects of neonatal allopregnanolone on striatal dopamine metabolism.
15 Jun 2009 Neurosteroids are known to modulate the development of the mesocorticolimbic system. We examined the effects of low (1 mg/kg) and high (10 mg/kg) doses of allopregnanolone on monoamine metabolism during the neonatal period (postnatal days 3-7) in ... Read more...
Latest indexed articles for 'Homovanillic Acid - Metabolism'
These are the very latest articles for this heading:
- A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. 30 Jul 2009
- Prenatal methamphetamine exposure affects the mesolimbic dopaminergic system and behavior in adult offspring. 6 Jul 2009
- Biphasic effects of neonatal allopregnanolone on striatal dopamine metabolism. 15 Jun 2009
- Developmental vitamin D deficiency alters dopamine turnover in neonatal rat forebrain. 5 Jun 2009
- Central l-proline attenuates stress-induced dopamine and serotonin metabolism in the chick forebrain. 16 May 2009
- Infantile hypokinetic-hypotonic syndrome due to two novel mutations of the tyrosine hydroxylase gene.
28 Apr 2009 - Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP.
27 Apr 2009 - Conversion of dehydrodiferulic acids by human intestinal microbiota. 20 Apr 2009
- Effects of cocaine self-administration history under limited and extended access conditions on in vivo striatal dopamine neurochemistry and acoustic startle in rhesus monkeys. 12 Apr 2009
- Acrylamide decreased dopamine levels and increased 3-nitrotyrosine (3-NT) levels in PC 12 cells. 9 Apr 2009
- In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid. 7 Apr 2009
- Metabolism of berry anthocyanins to phenolic acids in humans. 23 Mar 2009
- Behavioral and neurochemical profile of m-CPP following exposure to single restraint stress in rat. 27 Feb 2009
- Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide. 19 Feb 2009
- Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion. 18 Feb 2009
- Docosahexaenoic acid ethyl ester enhances 6-hydroxydopamine-induced neuronal damage by induction of lipid peroxidation in mouse striatum. 13 Feb 2009
- Dopamine and serotonin release in the nucleus accumbens during starvation-induced hyperactivity. 29 Jan 2009
- Enhanced dopamine D1 and D2 receptor gene expression in the hippocampus of hypoglycaemic and diabetic rats. 7 Jan 2009
- Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging. 14 Dec 2008
- An insight on the neuropharmacological activity of Telescopium telescopium--a mollusc from the Sunderban mangrove. 29 Nov 2008
See a longer list of these articles.
Technical information about 'Homovanillic Acid'
Chemical name: Benzeneacetic acid, 4-hydroxy-3-methoxy-
Registry Number: 306-08-1
Descriptor UI: D006719
Alternative terms: Homovanillic Acid; Acid, Homovanillic; 3-Methoxy-4-Hydroxyphenylacetic Acid; 3 Methoxy 4 Hydroxyphenylacetic Acid; Acid, 3-Methoxy-4-Hydroxyphenylacetic; 4-Hydroxy-3-Methoxyphenylacetic Acid; 4 Hydroxy 3 Methoxyphenylacetic Acid; Acid, 4-Hydroxy-3-Methoxyphenylacetic;
Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;
Tree Number: D02.241.223.601.521;
History Note: 86(73); was see under PHENYLACETATES 1975-85, was Prov 1973-74